Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UB-421 Monotherapy in Virologically Suppressed Adult HIV-1 Patients
CTR20191737Phase 3Active
- Sponsor
- United Biopharmaceutical Co., Ltd.
- Start
- May 2020
- Modality
- IgG Antibodies → Naked Antibodies → Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of semzuvolimab in Human immunodeficiency virus infection type 1, sponsored by United Biopharmaceutical Co., Ltd.. Started May 2020; status: active.
02
Drugs
semzuvolimab
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on CTR20191737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191737.